Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Nanoparticle drug delivery systems (nanoDDSs) enhance antitumor efficacy but face challenges in solid tumor penetration.
• Tumor-associated fibroblasts (TAFs) impede nanoDDS delivery by creating physical and physiological barriers.
• TAFs promote tumor growth and metastasis, making them critical targets for improved cancer therapy.

Purpose of the Study:

• To review the mechanisms by which TAFs obstruct nanoparticle drug delivery into tumors.
• To discuss current nanotherapeutic strategies for targeting TAFs to enhance anticancer agent delivery.

Main Methods:

• Literature review of studies on TAFs and nanoparticle drug delivery.
• Analysis of mechanisms of TAF-mediated obstruction of nanoDDS.
• Synthesis of advances in TAF-targeting nanotherapeutics.

Main Results:

• TAFs contribute significantly to the physical and physiological barriers within solid tumors.
• Targeting TAFs offers a promising strategy to improve nanoparticle distribution and penetration.
• Various nanotherapeutic approaches are being developed to specifically target TAFs.

Conclusions:

• Understanding TAF roles is crucial for overcoming nanoparticle delivery challenges in solid tumors.
• TAF-targeting nanotherapeutics represent a significant advancement in improving cancer treatment efficacy.
• Further research into TAF-specific nanomedicines is warranted to optimize drug delivery and patient outcomes.